Chiron's manufacturing misfortunes boost competitors.
作者信息
Sheridan Cormac
出版信息
Nat Biotechnol. 2005 Oct;23(10):1191. doi: 10.1038/nbt1005-1191.
PMID:16211043
Abstract
摘要
相似文献
1
Chiron's manufacturing misfortunes boost competitors.
Nat Biotechnol. 2005 Oct;23(10):1191. doi: 10.1038/nbt1005-1191.
2
Vaccines--why the US government must act.
Nat Biotechnol. 2005 Mar;23(3):287. doi: 10.1038/nbt0305-287a.
3
Next generation flu vaccine boosted by Chiron debacle.
Nat Biotechnol. 2004 Dec;22(12):1487-8. doi: 10.1038/nbt1204-1487.
4
Flu-like symptoms.
Revolution (Oakl). 2004 Nov-Dec;5(6):8-9.
5
Changing partners.
Nat Biotechnol. 2002 Sep;20(9):855. doi: 10.1038/nbt0902-855a.
6
From rhetoric to reality.
Nature. 2005 Oct 13;437(7061):927-8. doi: 10.1038/437927b.
7
The tiresome second best.
US News World Rep. 2004 Nov 1;137(15):51.
8
Plasma product companies outmuscle small recombinant players.
Nat Biotechnol. 2008 Oct;26(10):1060-1. doi: 10.1038/nbt1008-1060c.
9
When doses disappear. Flu shot shortage sheds light on drug supply chain.
Mod Healthc. 2004 Oct 18;34(42):16.
10
Roche and Igen in shotgun wedding.
Nat Biotechnol. 2003 Sep;21(9):958. doi: 10.1038/nbt0903-958a.
Zotero 插件